Lake Hills Wealth Management’s State Street SPDR S&P Biotech ETF XBI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$16M Buy
101,543
+907
+0.9% +$143K 7.36% 3
2026
Q2
$15.9M Buy
100,636
+8,663
+9% +$1.17M 7.24% 3
2026
Q1
$11.7M Buy
+91,973
New +$11.5M 6.57% 3
2024
Q3
– Sell
-22,360
Closed -$2.07M – 57
2024
Q2
$2.07M Buy
+22,360
New +$2M 1.49% 26

Other funds holding XBI

Lake Hills Wealth Management's XBI Position: Q3 2026 in Review

Lake Hills Wealth Management increased its State Street SPDR S&P Biotech ETF (XBI) stake by 0.9% in Q3 2026, buying an estimated $143K and bringing the position to 101,543 shares worth $16M. The position accounts for 7.36% of the portfolio, ranked #3.

Lake Hills Wealth Management first reported a position in XBI in Q2 2024 and has held it in 4 quarters since. 39 funds tracked by Wall St. Rank hold XBI as of Q3 2026.

  • Lake Hills Wealth Management held 101,543 shares of State Street SPDR S&P Biotech ETF worth $16M as of Q3 2026.
  • Lake Hills Wealth Management bought 907 State Street SPDR S&P Biotech ETF shares in Q3 2026, an estimated $143K.
  • State Street SPDR S&P Biotech ETF made up 7.36% of Lake Hills Wealth Management's portfolio in Q3 2026, its #3 holding.
  • Lake Hills Wealth Management first reported a position in State Street SPDR S&P Biotech ETF in Q2 2024 and has held it in 4 quarters since.
  • 39 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q3 2026.

Based on Lake Hills Wealth Management's 13F filing for Q3 2026, filed 7 Oct 2026.